Patent details
EP2229954 Title: Capsular polysaccharide solubilisation and combination vaccines
Basic Information
- Publication number:
- EP2229954
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP090750100
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Capsular polysaccharide solubilisation and combination vaccines
- French Title of Invention:
- Solubilisation de polysaccharides capsulaires et vaccins combinés
- German Title of Invention:
- Kapselartige Polysaccharidsolubilisations- und -kombinationsimpfstoffe
- SPC Number:
Dates
- Filing date:
- 20/06/2002
- Grant date:
- 21/03/2018
- EP Publication Date:
- 22/09/2010
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 21/03/2018
- EP B1 Publication Date:
- 21/03/2018
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 20/06/2018
- Expiration date:
- 20/06/2022
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 14/03/2018
- Name:
- GlaxoSmithKline Biologicals SA
- Address:
- Rue de l'Institut 89, 1330 Rixensart, Belgium (BE)
Inventor
- Name:
- Costantino, Paolo
- Address:
- Italy (IT)
Priority
- Priority Number:
- 0115176
- Priority Date:
- 20/06/2001
- Priority Country:
- United Kingdom (GB)
Classification
- IPC classification:
- A61K 39/095; A61K 39/385; A61P 31/04; C12P 19/04;
Publication
European Patent Bulletin
- Issue number:
- 201812
- Publication date:
- 21/03/2018
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 30/10/2018 | Outgoing Correspondence | 1 |